NRx Non Current Liabilities Total from 2010 to 2024

NRXPW Stock  USD 0.05  0  3.59%   
NRx Pharmaceuticals Non Current Liabilities Total yearly trend continues to be fairly stable with very little volatility. Non Current Liabilities Total will likely drop to 0.00 in 2024. During the period from 2010 to 2024, NRx Pharmaceuticals Non Current Liabilities Total regression line of quarterly data had mean square error of 327.5 B and geometric mean of 0.00. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2017-12-31
Previous Quarter
18.6 M
Current Value
M
Quarterly Volatility
24.7 M
 
Covid
Check NRx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRx Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 K, Interest Expense of 114 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRx financial statements analysis is a perfect complement when working with NRx Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRx Pharmaceuticals Correlation against competitors.
For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.

Latest NRx Pharmaceuticals' Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of NRx Pharmaceuticals over the last few years. It is NRx Pharmaceuticals' Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRx Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Pretty Stable
   Non Current Liabilities Total   
       Timeline  

NRx Non Current Liabilities Total Regression Statistics

Arithmetic Mean702,398
Geometric Mean0.00
Coefficient Of Variation79.03
Mean Deviation315,862
Median690,000
Standard Deviation555,096
Sample Variance308.1B
Range2M
R-Value(0.11)
Mean Square Error327.5B
R-Squared0.01
Significance0.69
Slope(14,127)
Total Sum of Squares4.3T

NRx Non Current Liabilities Total History

2023null
20221.8 M
2021 4205.0
2020548 K
2019M

About NRx Pharmaceuticals Financial Statements

NRx Pharmaceuticals investors use historical fundamental indicators, such as NRx Pharmaceuticals' Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NRx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NRx Stock Analysis

When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.